To view this email as a web page, click here.
 
Hypertension Rx in ESRD: A Quiz
Quiz: Hypertension in end-stage renal disease is both common and difficult to manage.
What's true and what's false?
 
SGLT2 Inhibitors Show Promise in REAL-CVD
Is cardioprotection in patients with type 2 diabetes a class effect for these drugs?
What is your take on CV outcomes data?
 
ADVERTISEMENT
Ad description here
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.